• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
NCEH1 may be a prognostic biomarker for pancreatic cancer.NCEH1可能是胰腺癌的一种预后生物标志物。
Int J Clin Exp Pathol. 2020 Nov 1;13(11):2746-2752. eCollection 2020.
2
Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis.基于生物信息学分析鉴定胰腺癌患者的预后脂质滴相关基因。
Lipids Health Dis. 2021 Jun 2;20(1):58. doi: 10.1186/s12944-021-01476-y.
3
The critical role of neutral cholesterol ester hydrolase 1 in cholesterol removal from human macrophages.中性胆固醇酯水解酶 1 在人巨噬细胞胆固醇清除中的关键作用。
Circ Res. 2010 Nov 26;107(11):1387-95. doi: 10.1161/CIRCRESAHA.110.226613. Epub 2010 Oct 14.
4
Retinoic acid receptor-related orphan receptor α reduces lipid droplets by upregulating neutral cholesterol ester hydrolase 1 in macrophages.维甲酸受体相关孤儿受体 α 通过上调巨噬细胞中的中性胆固醇酯水解酶 1 减少脂滴。
BMC Mol Cell Biol. 2020 Apr 22;21(1):32. doi: 10.1186/s12860-020-00276-z.
5
Abrogation of neutral cholesterol ester hydrolytic activity causes adrenal enlargement.胆固醇酯水解活性丧失导致肾上腺增大。
Biochem Biophys Res Commun. 2011 Jan 7;404(1):254-60. doi: 10.1016/j.bbrc.2010.11.103. Epub 2010 Nov 25.
6
In Vivo Imaging of the Tumor-Associated Enzyme NCEH1 with a Covalent PET Probe.利用共价 PET 探针对肿瘤相关酶 NCEH1 进行体内成像。
Angew Chem Int Ed Engl. 2020 Aug 24;59(35):15161-15165. doi: 10.1002/anie.202004762. Epub 2020 Jun 15.
7
Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.一种九基因特征的鉴定及预测胰腺癌总生存期的预后列线图的建立
Front Oncol. 2019 Sep 27;9:996. doi: 10.3389/fonc.2019.00996. eCollection 2019.
8
Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma.TFRC作为胰腺癌新型预后生物标志物及在免疫治疗中的作用
Front Mol Biosci. 2022 Mar 16;9:756895. doi: 10.3389/fmolb.2022.756895. eCollection 2022.
9
serves as a diagnostic and prognostic biomarker for pancreatic cancer.作为胰腺癌的诊断和预后生物标志物。
Onco Targets Ther. 2019 May 27;12:4141-4152. doi: 10.2147/OTT.S201675. eCollection 2019.
10
Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.生物信息学分析利用了九个免疫相关的长非编码 RNA 特征作为胰腺癌的预后靶点。
J Cell Biochem. 2019 Sep;120(9):14916-14927. doi: 10.1002/jcb.28754. Epub 2019 Apr 23.

引用本文的文献

1
Kernel-based hierarchical structural component models for pathway analysis on survival phenotype.基于核的层次结构成分模型在生存表型的通路分析。
Genes Genomics. 2024 Dec;46(12):1415-1421. doi: 10.1007/s13258-024-01569-9. Epub 2024 Sep 26.
2
Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells.脂肪酸可消除胰腺癌细胞中胆固醇通量抑制所诱导的生长抑制作用。
Cancer Cell Int. 2023 Nov 17;23(1):276. doi: 10.1186/s12935-023-03138-8.
3
Cholesterol Metabolism in Pancreatic Cancer.胰腺癌中的胆固醇代谢
Cancers (Basel). 2023 Oct 27;15(21):5177. doi: 10.3390/cancers15215177.
4
KIAA1363-A Multifunctional Enzyme in Xenobiotic Detoxification and Lipid Ester Hydrolysis.KIAA1363——一种参与外源性物质解毒和脂质酯水解的多功能酶
Metabolites. 2022 Jun 2;12(6):516. doi: 10.3390/metabo12060516.
5
Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis.基于生物信息学分析鉴定胰腺癌患者的预后脂质滴相关基因。
Lipids Health Dis. 2021 Jun 2;20(1):58. doi: 10.1186/s12944-021-01476-y.
6
Bioactive Ether Lipids: Primordial Modulators of Cellular Signaling.生物活性醚脂类:细胞信号传导的原始调节剂
Metabolites. 2021 Jan 8;11(1):41. doi: 10.3390/metabo11010041.

本文引用的文献

1
Pancreatic cancer: challenges and opportunities.胰腺癌:挑战与机遇。
BMC Med. 2018 Nov 22;16(1):214. doi: 10.1186/s12916-018-1215-3.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
Challenges in diagnosis of pancreatic cancer.胰腺癌诊断的挑战。
World J Gastroenterol. 2018 May 21;24(19):2047-2060. doi: 10.3748/wjg.v24.i19.2047.
4
Pancreatic Cancer and Depression: A Narrative Review.胰腺癌与抑郁症:一篇叙述性综述
J Nerv Ment Dis. 2017 Jun;205(6):487-490. doi: 10.1097/NMD.0000000000000593.
5
Optimal design of the Wilcoxon-Mann-Whitney-test.威尔科克森-曼-惠特尼检验的优化设计
Biom J. 2017 Jan;59(1):25-40. doi: 10.1002/bimj.201600022. Epub 2016 May 31.
6
The Genotype-Tissue Expression (GTEx) Project.基因型-组织表达(GTEx)项目
Biopreserv Biobank. 2015 Oct;13(5):307-8. doi: 10.1089/bio.2015.29031.hmm.
7
The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.癌症基因组图谱(TCGA):一个不可估量的知识来源。
Contemp Oncol (Pozn). 2015;19(1A):A68-77. doi: 10.5114/wo.2014.47136.
8
Absence of Nceh1 augments 25-hydroxycholesterol-induced ER stress and apoptosis in macrophages.Nceh1缺失增强了25-羟基胆固醇诱导的巨噬细胞内质网应激和细胞凋亡。
J Lipid Res. 2014 Oct;55(10):2082-92. doi: 10.1194/jlr.M050864. Epub 2014 Jun 2.
9
Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity.醚脂生成酶 AGPS 改变了结构脂质和信号脂质的平衡,为癌症的发病机制提供燃料。
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):14912-7. doi: 10.1073/pnas.1310894110. Epub 2013 Aug 26.
10
Synthesis and structure-activity relationship of (1-halo-2-naphthyl) carbamate-based inhibitors of KIAA1363 (NCEH1/AADACL1).(1-卤代-2-萘基)氨基甲酸酯类 KIAA1363(NCEH1/AADACL1)抑制剂的合成及构效关系。
Bioorg Med Chem Lett. 2012 Sep 1;22(17):5748-51. doi: 10.1016/j.bmcl.2012.05.102. Epub 2012 Jun 6.

NCEH1可能是胰腺癌的一种预后生物标志物。

NCEH1 may be a prognostic biomarker for pancreatic cancer.

作者信息

Lu Yan, Zhang Longyi, Chen Xuya, Zhang Qiaohong

机构信息

Clinical Laboratory, Dongyang People's Hospital 60 West Wuning Road, Dongyang 322100, Zhejiang, China.

出版信息

Int J Clin Exp Pathol. 2020 Nov 1;13(11):2746-2752. eCollection 2020.

PMID:33284889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7716126/
Abstract

Neutral Cholesterol Ester Hydrolase 1 (NCEH1) is an enzyme involved in ether lipid metabolism, and the gene is overexpressed in a variety of tumors. However, its role in pancreatic cancer remains unknown. Therefore, we compared the gene transcription data of healthy and pancreatic cancer tissues using the Cancer Genome Atlas and Genotype-Tissue Expression databases. R software (v3.6.1) was used for the differential, clinicopathological correlation, and survival analyses. We found that was overexpressed in pancreatic cancer tissues compared with that in healthy tissues ( = 1.732 e-50), and that its expression level was related to lymph node metastasis. High expression was associated with poor overall survival ( = 0.002). Using univariate and multivariate Cox regression analyses, we determined that is an independent risk factor for pancreatic cancer. Gene set enrichment analysis identified that overexpression is prominent in cell-cell adhesion junctions, pancreatic cancer, cancer-associated pathways, prostate cancer, and chronic myeloid leukemia. In contrast, low expression correlated to high oxidative phosphorylation. Thus, we conclude that may be a prognostic biomarker for pancreatic cancer.

摘要

中性胆固醇酯水解酶1(NCEH1)是一种参与醚脂代谢的酶,该基因在多种肿瘤中过表达。然而,其在胰腺癌中的作用尚不清楚。因此,我们使用癌症基因组图谱(Cancer Genome Atlas)和基因型-组织表达(Genotype-Tissue Expression)数据库比较了健康组织和胰腺癌组织的基因转录数据。使用R软件(v3.6.1)进行差异分析、临床病理相关性分析和生存分析。我们发现,与健康组织相比,NCEH1在胰腺癌组织中过表达(P = 1.732×10⁻⁵⁰),且其表达水平与淋巴结转移有关。高NCEH1表达与总体生存率低相关(P = 0.002)。通过单因素和多因素Cox回归分析,我们确定NCEH1是胰腺癌的独立危险因素。基因集富集分析表明,NCEH1过表达在细胞-细胞黏附连接、胰腺癌、癌症相关通路、前列腺癌和慢性髓性白血病中显著。相反,低NCEH1表达与高氧化磷酸化相关。因此,我们得出结论,NCEH1可能是胰腺癌的预后生物标志物。